title: Individual dosing regimen of mycophenolate mofetil in lupus patients: comment on the article by Zahr et al.
authors.forename: A
authors.initials: A
authors.lastname: Thomas-Schoemann
authors.forename: F
authors.initials: F
authors.lastname: Batteux
authors.forename: B
authors.initials: B
authors.lastname: Weill
authors.forename: A
authors.initials: A
authors.lastname: Dauphin
authors.forename: B
authors.initials: B
authors.lastname: Blanchet
mesh_terms: D019540:Area Under Curve; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics
chemical_list: D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid